Ming-shi Chang

Title: The Innovations of Ming-shi Chang

Introduction

Ming-shi Chang is a notable inventor based in Newbury Park, California. He has made significant contributions to the field of biotechnology, particularly in the development of neurotrophic factors. With a total of four patents to his name, his work has implications for immunology and therapeutic applications.

Latest Patents

Chang's latest patents include groundbreaking research on antibodies to the neurotrophic factor NNT-1. This patent discloses nucleic acids encoding novel neurotrophic factors, designated NNT-1. It also includes amino acid sequences for NNT-1 polypeptides, methods for preparing these polypeptides, and other related aspects. These polypeptides are active in stimulating B-cell and/or T cell production, as well as reducing inflammatory responses. Another significant patent involves nucleic acid molecules encoding the neurotrophic factor NNT-1, further emphasizing the importance of this research in the field.

Career Highlights

Ming-shi Chang is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions that address critical health challenges. His contributions have been instrumental in advancing the understanding of neurotrophic factors and their potential therapeutic uses.

Collaborations

Chang has collaborated with notable colleagues, including William James Boyle and David L Lacey. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.

Conclusion

Ming-shi Chang's innovative work in the field of neurotrophic factors exemplifies the impact of biotechnology on health and medicine. His patents reflect a commitment to advancing scientific knowledge and improving therapeutic options.